I-Zrhmed® Sclerotherapy Inaliti ihloselwe ukusetshenziselwa umjovo we-endoscopic wama-sclerotherapy agents kanye namadayi abe yinzuzo ye-esophageal noma yekoloni. Kuboniswa futhi ukuthi kufakwa usawoti ukuze kusiza ekuvuseleleni ama-mucosal e-endoscopic (EMR) nezinqubo zePollyPectomy. Umjovo we-saline ukusiza e-endoscopic mucosal resection (EMR), izinqubo ze-polypectomy kanye nokulawula okungelona nomoya we-hamorrhage.
Isifanekiso | Sheath Odd ± 0.1 (MM) | Ubude obusebenzayo l ± 50 (mm) | Usayizi wenaliti (ububanzi / ubude) | Isiteshi se-Endoscopic (mm) |
Zrh-pn-2418-214 | Φ2.4 | 1800 | I-21G, 4mm | ≥2.8 |
Zrh-pn-2418-234 | Φ2.4 | 1800 | 23g, 4mm | ≥2.8 |
Zrh-pn-2418-254 | Φ2.4 | 1800 | 25G, 4mm | ≥2.8 |
Zrh-pn-2418-216 | Φ2.4 | 1800 | I-21G, 6mm | ≥2.8 |
Zrh-pn-2418-236 | Φ2.4 | 1800 | 23g, 6mm | ≥2.8 |
Zrh-pn-2418-256 | Φ2.4 | 1800 | 25G, 6mm | ≥2.8 |
Zrh-pn-2423-214 | Φ2.4 | I-2300 | I-21G, 4mm | ≥2.8 |
Zrh-pn-2423-234 | Φ2.4 | I-2300 | 23g, 4mm | ≥2.8 |
Zrh-pn-2423-254 | Φ2.4 | I-2300 | 25G, 4mm | ≥2.8 |
Zrh-pn-2423-216 | Φ2.4 | I-2300 | I-21G, 6mm | ≥2.8 |
Zrh-pn-2423-236 | Φ2.4 | I-2300 | 23g, 6mm | ≥2.8 |
Zrh-pn-2423-256 | Φ2.4 | I-2300 | 25G, 6mm | ≥2.8 |
I-Willle Tip Angel 30 Degree
Ukubhoboza okubukhali
Ishubhu elingaphakathi elingaphakathi
Ingasetshenziswa ukubheka ukubuya kwegazi.
Ukwakhiwa okuqinile kwe-Ptfe Sheath
Kusiza ukuthuthuka ngezindlela ezinzima.
Design we-ergonomic Handle
Kulula ukulawula inaliti ehambayo.
Inaliti ye-sclerotherapy elahlekile esebenza ngayo
Inaliti ye-Sclerotherapy isetshenziselwa ukujova uketshezi endaweni ephansi yokuphakamisa isilonda kude nesisekelo se-muscularis propria futhi yakha ilitshe elincane lokuvunyelwa kabusha.
.
Inaliti ye-Sclerotherapy isetshenziselwa ukujova uketshezi endaweni ephansi yokuphakamisa isilonda kude nesisekelo se-muscularis propria futhi yakha ilitshe elincane lokuvunyelwa kabusha. Umjovo uvame ukwenziwa nge-saline, kepha ezinye izixazululo zisetshenziselwe ukufezekisa ukulungiswa okuzayo kwe-bleb kufaka phakathi usawoti we-hypertonic (3.75% nacl), ama-20% i-haxtrose, noma i-sodium hyaluronate [2]. I-Indigo Carmine (0.004%) noma i-methylene eluhlaza okwesibhakabhaka ivame ukungezwa ku-infate yokubala i-subrucosa futhi ihlinzeka ngokuhlola okungcono kokujula kabusha kokuvuselelwa kabusha. Umjovo we-submucosal nawo ungasetshenziswa ukuthola ukuthi ngabe i-lesion ilungele ukusetha kabusha kwe-endoscopic. Ukuntuleka kokuphakama ngesikhathi umjovo kukhombisa ukubambelela kuma-muscularis propria futhi kuyinto ephikisana nesihlobo sokuqhubeka ne-EMR. Ngemuva kokudala ukuphakama kwe-submucosal, i-lesion ibanjwa ne-rat yezinyo lamandla adluliswa isigaxa esivulekile se-polyperpecy. Amandla aphakamisa i-lesion kanye nogibe licindezelwa phansi eduze kwesisekelo salo kanye nokubuyiselwa kabusha kuqinisekisa. Le ndlela "yokufinyelela" "idinga i-endoscope ephindwe kabili engahle ibe yinhle ukusetshenziswa kwi-esophagus. Ngenxa yalokhu, amasu wokuphakamisa nokusika asetshenziswa kaningi kakhulu kwizilonda ze-esophageal.